» Articles » PMID: 30873475

Scorpion and Spider Venoms in Cancer Treatment: State of the Art, Challenges, and Perspectives

Overview
Date 2019 Mar 16
PMID 30873475
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Animal venoms comprise a mix of bioactive molecules with high affinity for multiple targets in cells and tissues. Scorpion and spider venoms and purified peptides exhibit significant effects on cancer cells, encompassing four potential mechanisms: 1) induction of cell cycle arrest, growth inhibition, and apoptosis; 2) inhibition of angiogenesis; 3) inhibition of invasion and metastasis; and 4) blocking of specific transmembrane channels. Tumor biology is complex and entails many intertwined processes, as reflected in the putative hallmarks of cancer. This complexity, however, gives rise to numerous (potential) pharmacological intervention sites. Molecules that target multiple proteins or pathways, such as components of animal venoms, may therefore be effective anti-cancer agents. The objective of this review was to address the anti-cancer properties and in vitro mechanisms of scorpion and spider venoms and toxins, and highlight current obstacles in translating the preclinical research to a clinical setting. Cancer is a considerable global contributor to disease-related death. Despite some advances being made, therapy remains palliative rather than curative for the majority of cancer indications. Consequently, more effective therapies need to be devised for poorly responding cancer types to optimize clinical cancer management. Scorpion and spider venoms may occupy a role in the development of improved anti-cancer modalities.

Citing Articles

scorpion venom induces G2/M cell cycle arrest and apoptotic cell death in human non-small lung cancer cell lines.

Diaz-Garcia A, Garrido A, Ruiz-Fuentes J, Hermosilla T, Varela D J Venom Anim Toxins Incl Trop Dis. 2025; 31:e20240035.

PMID: 39906356 PMC: 11792888. DOI: 10.1590/1678-9199-JVATITD-2024-0035.


Anticancer potentiality of Hottentotta saulcyi scorpion curd venom against breast cancer: an in vitro and in vivo study.

Nosouhian M, Rastegari A, Shahanipour K, Ahadi A, Sajjadieh M Sci Rep. 2024; 14(1):24607.

PMID: 39427017 PMC: 11490606. DOI: 10.1038/s41598-024-75183-w.


Yellow scorpion (Buthus sinidicus) venom peptides induce mitochondrial-mediated apoptosis in cervical, prostate and brain tumor cell lines.

Hassan H, Mirza M, Jabeen A, Alam M, Kori J, Sultan R PLoS One. 2024; 19(2):e0296636.

PMID: 38394321 PMC: 10890731. DOI: 10.1371/journal.pone.0296636.


Anticancer Effect of Theranekron on Androgen-Dependent Prostate Cancer Cells.

Erzurumlu Y, Kubra Dogan H, Catakli D Turk J Pharm Sci. 2024; 20(6):368-373.

PMID: 38254333 PMC: 10803929. DOI: 10.4274/tjps.galenos.2023.47905.


Protein and peptide profiles of rats' organs in scorpion envenomation.

Gunas V, Maievskyi O, Raksha N, Vovk T, Savchuk O, Shchypanskyi S Toxicol Rep. 2023; 10:615-620.

PMID: 37234066 PMC: 10208795. DOI: 10.1016/j.toxrep.2023.05.008.


References
1.
Guo X, Ma C, Du Q, Wei R, Wang L, Zhou M . Two peptides, TsAP-1 and TsAP-2, from the venom of the Brazilian yellow scorpion, Tityus serrulatus: evaluation of their antimicrobial and anticancer activities. Biochimie. 2013; 95(9):1784-94. DOI: 10.1016/j.biochi.2013.06.003. View

2.
Das Gupta S, Debnath A, Saha A, Giri B, Tripathi G, Vedasiromoni J . Indian black scorpion (Heterometrus bengalensis Koch) venom induced antiproliferative and apoptogenic activity against human leukemic cell lines U937 and K562. Leuk Res. 2006; 31(6):817-25. DOI: 10.1016/j.leukres.2006.06.004. View

3.
Newman D, Cragg G . Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod. 2012; 75(3):311-35. PMC: 3721181. DOI: 10.1021/np200906s. View

4.
DeBin J, Maggio J, Strichartz G . Purification and characterization of chlorotoxin, a chloride channel ligand from the venom of the scorpion. Am J Physiol. 1993; 264(2 Pt 1):C361-9. DOI: 10.1152/ajpcell.1993.264.2.C361. View

5.
Fan S, Sun Z, Jiang D, Dai C, Ma Y, Zhao Z . BmKCT toxin inhibits glioma proliferation and tumor metastasis. Cancer Lett. 2009; 291(2):158-66. DOI: 10.1016/j.canlet.2009.10.011. View